The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 27 June 2005 doi:10.1084/jem.20050146
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 202, Number 1, 21-31
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2103K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benz, C.
Right arrow Articles by Bleul, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benz, C.
Right arrow Articles by Bleul, C. C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

A multipotent precursor in the thymus maps to the branching point of the T versus B lineage decision

Claudia Benz and Conrad C. Bleul

Department of Developmental Immunology, Max-Planck-Institute for Immunobiology, 79108 Freiburg, Germany

CORRESPONDENCE Conrad C. Bleul: bleul{at}immunbio.mpg.de

Hematopoietic precursors continuously colonize the thymus where they give rise mainly to T cells, but also to B and dendritic cells. The lineage relationship between these three cell types is unclear, and it remains to be determined if precursors in the thymus are multipotent, oligopotent, or lineage restricted. Resolution of this question necessitates the determination of the clonal differentiation potential of the most immature precursors in the thymus. Using a CC chemokine receptor 9–enhanced green fluorescent protein knock-in allele like a surface marker of unknown function, we identify a multipotent precursor present in bone marrow, blood, and thymus. Single cells of this precursor give rise to T, B, and dendritic cells. A more differentiated stage of this multipotent precursor in the thymus has lost the capacity to generate B but not T, dendritic, and myeloid cells. Thus, the newly identified precursor maps to the branching point of the T versus B lineage decision in the hematopoietic lineage hierarchy.


Abbreviations used: CCR9, CC chemokine receptor 9; CLP, common lymphoid progenitor; DN, double negative; EGFP, enhanced GFP; ETP, early T lineage progenitor; FTOC, fetal thymic organ culture; HSC, hematopoietic stem cell; LSK, LinSca-1+c-kit+; SCF, stem cell factor; TMP, thymic multipotent precursor.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Progenitor of all trades
Heather L. Van Epps
J. Exp. Med. 2005 202: 3. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS